Please login to the form below

Not currently logged in
Email:
Password:

opioid addiction

This page shows the latest opioid addiction news and features for those working in and with pharma, biotech and healthcare.

Brexit contributes to surge in generic drug prices

Brexit contributes to surge in generic drug prices

He says some medicines would be “particularly vulnerable" - highlighting a current shortage of pain and opioid addiction treatment Buprenorphine and antipsychotic Risperidone, arising in particular because there are no simple alternatives

Latest news

  • FDA awards another non-opioid pain drug breakthrough status FDA awards another non-opioid pain drug breakthrough status

    Second drug fast-tracked amid addiction epidemic. The FDA is prioritising the approval of new non-opioid pain treatments, as part of the US battle against its opioid addiction epidemic. ... prevent more people becoming addicted to opioid painkillers

  • Regeneron and Teva close gap on rivals with NGF pain drug Regeneron and Teva close gap on rivals with NGF pain drug

    Nevertheless, fasinumab and tanezumab are now leading what analysts consider could be a highly-lucrative market for drugs that deliver effective pain relief without the risk of side effects and addiction ... In contrast to opioids, which alter pain

  • Indivior push to diversify boosted by schizophrenia drug approval Indivior push to diversify boosted by schizophrenia drug approval

    For years, Indivior has made the bulk of its revenues from opioid addiction treatment Suboxone. ... Perseris is a key product in Indivior’s diversification plans, along with newer painkiller addiction therapy Sublocade (long-acting buprenorphine) which

  • The year of the blockbuster The year of the blockbuster

    The diseases targeted by the report’s projected market entrants include type 2 diabetes, endometriosis, childhood epilepsy, haemophilia, HIV, migraine, opioid addiction and shingles. ... Sublocade (buprenorphine) from Indivior:Sublocade, having been

  • Heron boosted by new data for ‘breakthrough’ pain drug Heron boosted by new data for ‘breakthrough’ pain drug

    opioid analgesics compared to both placebo and local anaesthesia monotherapy with bupivacaine in the first 48 hours after surgery. ... The reduction in opioid use is another important facet of the new therapy, given the US’s current epidemic of opioid

More from news
Approximately 2 fully matching, plus 13 partially matching documents found.

Latest Intelligence

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    11. Buvidal – an advance in opioid dependence treatment. Opioid addiction has surged in the US since the 1990s, when prescription drugs such as OxyContin and Vicodin became a common remedy for ... The US market for the treatment of opioid addiction is

  • Pharma deals during November 2014 Pharma deals during November 2014

    Indivior will not be without its challenges as sales of its off-patent opioid addiction treatment Suboxone continue to slump.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...
The 10-year Web Challenge
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....

Infographics